Astellas Pharma, Inc. earnings per share and revenue

ALPMY earnings per share for the last quarter are 0.13 USD whereas the estimation was 0.12 USD which accounts for 8.96% surprise. Company revenue for the same period amounts to 3.04 B USD despite the estimated figure of 2.96 B USD. Estimated earnings per share for the next quarter are 0.12 USD, and revenue is expected to reach 2.98 B USD. Also watch annual changes over time to get a bigger picture of ALPMY earnings per share and revenue dynamics.